Literature DB >> 15051280

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.

Valerie Beral, Diana Bull, Richard Doll, Richard Peto, Gillian Reeves.   

Abstract

BACKGROUND: The Collaborative Group on Hormonal Factors in Breast Cancer has brought together the worldwide epidemiological evidence on the possible relation between breast cancer and previous spontaneous and induced abortions.
METHODS: Data on individual women from 53 studies undertaken in 16 countries with liberal abortion laws were checked and analysed centrally. Relative risks of breast cancer--comparing the effects of having had a pregnancy that ended as an abortion with those of never having had that pregnancy--were calculated, stratified by study, age at diagnosis, parity, and age at first birth. Because the extent of under-reporting of past induced abortions might be influenced by whether or not women had been diagnosed with breast cancer, results of the studies--including a total of 44000 women with breast cancer--that used prospective information on abortion (ie, information that had been recorded before the diagnosis of breast cancer) were considered separately from results of the studies--including 39000 women with the disease--that used retrospective information (recorded after the diagnosis of breast cancer).
FINDINGS: The overall relative risk of breast cancer, comparing women with a prospective record of having had one or more pregnancies that ended as a spontaneous abortion versus women with no such record, was 0.98 (95% CI 0.92-1.04, p=0.5). The corresponding relative risk for induced abortion was 0.93 (0.89-0.96, p=0.0002). Among women with a prospective record of having had a spontaneous or an induced abortion, the risk of breast cancer did not differ significantly according to the number or timing of either type of abortion. Published results on induced abortion from the few studies with prospectively recorded information that were not available for inclusion here are consistent with these findings. Overall results for induced abortion differed substantially between studies with prospective and those with retrospective information on abortion (test for heterogeneity between relative risks: chi2(1) =33.1, p<0.0001).
INTERPRETATION: Pregnancies that end as a spontaneous or induced abortion do not increase a woman's risk of developing breast cancer. Collectively, the studies of breast cancer with retrospective recording of induced abortion yielded misleading results, possibly because women who had developed breast cancer were, on average, more likely than other women to disclose previous induced abortions.

Entities:  

Mesh:

Year:  2004        PMID: 15051280     DOI: 10.1016/S0140-6736(04)15835-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  42 in total

Review 1.  Early breast cancer.

Authors:  Tomoyoshi Suzuki; Masakazu Toi; Shigehira Saji; Kazumi Horiguchi; Tomoyuki Aruga; Eiji Suzuki; Shinichiro Horiguchi; Nobuaki Funata; Katsuyuki Karasawa; Noriko Kamata
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

Review 2.  Reproduction and breast cancer risk.

Authors:  Volker Hanf; Dorothea Hanf
Journal:  Breast Care (Basel)       Date:  2014-12       Impact factor: 2.860

3.  Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Authors:  Nadine Andrieu; David E Goldgar; Douglas F Easton; Matti Rookus; Richard Brohet; Antonis C Antoniou; Susan Peock; Gareth Evans; Diana Eccles; Fiona Douglas; Catherine Noguès; Marion Gauthier-Villars; Agnès Chompret; Flora E Van Leeuwen; Irma Kluijt; Javier Benitez; Brita Arver; Edith Olah; Jenny Chang-Claude
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

4.  Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study.

Authors:  Ningqi Hou; Temidayo Ogundiran; Oladosu Ojengbede; Imran Morhason-Bello; Yonglan Zheng; James Fackenthal; Clement Adebamowo; Imaria Anetor; Stella Akinleye; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Ann Epidemiol       Date:  2013-07-20       Impact factor: 3.797

5.  Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis.

Authors:  Yogi Misra; Pamela A Bentley; Jeffrey P Bond; Scott Tighe; Timothy Hunter; Feng-Qi Zhao
Journal:  Physiol Genomics       Date:  2011-11-15       Impact factor: 3.107

Review 6.  Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature.

Authors:  Sarah Nechuta; Nigel Paneth; Ellen M Velie
Journal:  Cancer Causes Control       Date:  2010-03-12       Impact factor: 2.506

7.  Incomplete pregnancy is not associated with breast cancer risk: the California Teachers Study.

Authors:  Katherine DeLellis Henderson; Jane Sullivan-Halley; Peggy Reynolds; Pamela L Horn-Ross; Christina A Clarke; Ellen T Chang; Susan Neuhausen; Giske Ursin; Leslie Bernstein
Journal:  Contraception       Date:  2008-04-18       Impact factor: 3.375

8.  Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.

Authors:  Renée T Fortner; Helena Schock; Rudolf Kaaks; Matti Lehtinen; Eero Pukkala; Hans-Åke Lakso; Minna Tanner; Raija Kallio; Heikki Joensuu; Kjell Grankvist; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Eva Lundin; Helja-Marja Surcel
Journal:  Cancer Res       Date:  2014-10-03       Impact factor: 12.701

9.  Differences in reproductive risk factors for breast cancer in middle-aged women in Marin County, California and a sociodemographically similar area of Northern California.

Authors:  C Suzanne Lea; Nancy P Gordon; Lee Ann Prebil; Rochelle Ereman; Connie S Uratsu; Mark Powell
Journal:  BMC Womens Health       Date:  2009-03-25       Impact factor: 2.809

10.  Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies.

Authors: 
Journal:  Lancet Oncol       Date:  2012-10-17       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.